(CTA) expression after exposure to 5-aza-2'-deoxycytidine in HCT116 cells
收藏官方服务：
资源简介：
(CTA) expression after exposure to 5-aza-2'-deoxycytidine in HCT116 cells
应用场景：
创建时间：
2016-05-31
相关数据集
Representative genes whose expression is significantly altered by TSA treatment.
Gene symbols are listed along with their kinetic cluster number describing their normal expression during oligodendrocyte differentiation (see figure 1), the functional gene ontology groups which they
NIAID Data Ecosystem100
Gene expression of PBMC and isolated CD4 T cells from participants in Part A REDUC clinical trial
REDUC Part A (NCT02092116) assessed the effect of romidepsin in ART-treated chronically HIV-1 infected individuals. Here, we studied the gene expression on PBMCs or isolated CD4 before and after the 3
NIAID Data Ecosystem60
5-aza-2'-cytidine and trichostatin A effect to gene expression of Epstein-Barr virus-transformed human lymphoblastoid cell lines (LCLs).
5-aza-2'-cytidine and trichostatin A effect to gene expression of Epstein-Barr virus-transformed human lymphoblastoid cell lines (LCLs).
ChEBI2012-01-27 更新00
DNA methylation and gene expression changes induced by hypomethylating agent, Azacitidine (AZA), BAY1436032 (BAY) and sequential and simultaneous combination of BAY and AZA in in vitro treated human (CD45+) cells isolated from the bone marrow of IDH1mut. DNA methylation and gene expression changes induced by hypomethylating agent, Azacitidine (AZA), BAY1436032 (BAY) and sequential and simultaneous combination of BAY and AZA in in vitro treated human (CD45+) cells isolated from the bone marrow of IDH1mut
This SuperSeries is composed of the SubSeries listed below. Overall design: Refer to individual Series
NIAID Data Ecosystem70
Inhibition of a G9a/DNMT network triggers an immune-mediated bladder cancer regression treated with CM272 (IC50). Inhibition of a G9a/DNMT network triggers an immune-mediated bladder cancer regression treated with CM272 (IC50)
Based on the identification of G9a as a potential target in BC, we decided to test the effect of a recently described dual inhibitor against G9a/DNMTs, CM-272, in several BC cell lines Overall design:
NIAID Data Ecosystem20
